Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Jul 17;14(14):5055.
doi: 10.3390/jcm14145055.

Closing Editorial for the Special Issue: Cardiac Electrophysiology and Catheter Ablation of Different Arrhythmias

Affiliations
Editorial

Closing Editorial for the Special Issue: Cardiac Electrophysiology and Catheter Ablation of Different Arrhythmias

Hussam Ali et al. J Clin Med. .

Abstract

Cardiac electrophysiology and catheter ablation for diverse arrhythmic substrates continue to evolve rapidly, leveraging new techniques and energy sources [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Ezzat V.A., Lee V., Ahsan S., Chow A.W., Segal O., Rowland E., Lowe M.D., Lambiase P.D. A systematic review of ICD complications in randomised controlled trials versus registries: Is our ‘real-world’ data an underestimation? Open Heart. 2015;2:e000198. doi: 10.1136/openhrt-2014-000198. - DOI - PMC - PubMed
    1. Zaher W., Della Rocca D.G., Pannone L., Boveda S., de Asmundis C., Chierchia G.B., Sorgente A. Anti-Arrhythmic Effects of Heart Failure Guideline-Directed Medical Therapy and Their Role in the Prevention of Sudden Cardiac Death: From Beta-Blockers to Sodium-Glucose Cotransporter 2 Inhibitors and Beyond. J. Clin. Med. 2024;13:1316. doi: 10.3390/jcm13051316. - DOI - PMC - PubMed
    1. Goldenberg I., Ezekowitz J., Albert C., Alexis J.D., Anderson L., Behr E.R., Daubert J., Di Palo K.E., Ellenbogen K.A., Dzikowicz D.J., et al. Reassessing the need for primary prevention implantable cardioverter-defibrillators in contemporary patients with heart failure. Heart Rhythm. 2025;22:1040–1051. doi: 10.1016/j.hrthm.2024.10.078. - DOI - PubMed
    1. Scolari F.L., Garbin H.I., de Carvalho G.D., Rodrigues F.T., de Menezes R.A., Correia E.B., Bittencourt M.I. Low agreement among guidelines for primary prevention implantable cardioverter-defibrillator recommendations in hypertrophic cardiomyopathy. Am. J. Cardiol. 2025;236:86–91. doi: 10.1016/j.amjcard.2024.11.007. - DOI - PubMed
    1. Sclafani M., Falasconi G., Tini G., Musumeci B., Penela D., Saglietto A., Arcari L., Bucciarelli-Ducci C., Barbato E., Berruezo A., et al. Substrates of Sudden Cardiac Death in Hypertrophic Cardiomyopathy. J. Clin. Med. 2025;14:1331. doi: 10.3390/jcm14041331. - DOI - PMC - PubMed

Publication types

LinkOut - more resources